Session

IBD (Posters)

ROLE OF P2X7 IN INTESTINAL FIBROSIS AND INFLAMMASOME ACTIVATION: RELEVANCE IN CROHN'S DISEASE
ROLE OF P2X7 IN INTESTINAL FIBROSIS AND INFLAMMASOME ACTIVATION: RELEVANCE IN CROHN'S DISEASE

A 12-WEEK TAILORED PHYSICAL TRAINING PROGRAM INCLUDING DIETARY ADVICE IN CHILDREN WITH INFLAMMATORY BOWEL DISEASE: A RANDOMIZED CROSSOVER TRIAL.
A 12-WEEK TAILORED PHYSICAL TRAINING PROGRAM INCLUDING DIETARY ADVICE IN CHILDREN WITH INFLAMMATORY BOWEL DISEASE: A RANDOMIZED CROSSOVER TRIAL.

IMPACT OF EXCLUSIVE ENTERAL NUTRITION ON INTESTINAL HOMEOSTASIS IN A MOUSE MODEL OF COLITIS
IMPACT OF EXCLUSIVE ENTERAL NUTRITION ON INTESTINAL HOMEOSTASIS IN A MOUSE MODEL OF COLITIS

BENEFICIAL EFFECTS OF NATURAL MINERAL WATERS ON INTESTINAL INFLAMMATION AND THE MUCOSA-ASSOCIATED MICROBIOTA
BENEFICIAL EFFECTS OF NATURAL MINERAL WATERS ON INTESTINAL INFLAMMATION AND THE MUCOSA-ASSOCIATED MICROBIOTA

THE CORRELATION BETWEEN 6-THIOGUANINE NUCLEOTIDE CONCENTRATIONS AND LEUKOCYTE FRACTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE RECEIVING THIOPURINE TREATMENT
THE CORRELATION BETWEEN 6-THIOGUANINE NUCLEOTIDE CONCENTRATIONS AND LEUKOCYTE FRACTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE RECEIVING THIOPURINE TREATMENT

SYSTEMATIC REVIEW ON THE USE OF ENTERAL NUTRITION FOR THE INDUCTION OF REMISSION IN PAEDIATRIC CROHN'S DISEASE
SYSTEMATIC REVIEW ON THE USE OF ENTERAL NUTRITION FOR THE INDUCTION OF REMISSION IN PAEDIATRIC CROHN'S DISEASE

PROPENSITY SCORE ADJUSTED REAL WORLD EFFECTIVENESS OF VEDOLIZUMAB VS. ANTI-TNF IN BIOLOGIC-NAÏVE ULCERATIVE COLITIS PATIENTS: INDUCTION PHASE RESULTS FROM THE PROSPECTIVE, OBSERVATIONAL VEDOIBD STUDY IN GERMANY
PROPENSITY SCORE ADJUSTED REAL WORLD EFFECTIVENESS OF VEDOLIZUMAB VS. ANTI-TNF IN BIOLOGIC-NAÏVE ULCERATIVE COLITIS PATIENTS: INDUCTION PHASE RESULTS FROM THE PROSPECTIVE, OBSERVATIONAL VEDOIBD STUDY IN GERMANY

FAECAL MICROBIAL TRANSPLANTATION VERSUS 5-ASA ENEMA FOR TREATMENT OF ACTIVE LEFT-SIDED ULCERATIVE COLITIS - RESULTS FROM RANDOMIZED CONTROL TRIAL FACTU
FAECAL MICROBIAL TRANSPLANTATION VERSUS 5-ASA ENEMA FOR TREATMENT OF ACTIVE LEFT-SIDED ULCERATIVE COLITIS - RESULTS FROM RANDOMIZED CONTROL TRIAL FACTU

IMMUNOLOGICAL MECHANISMS BEHIND RESISTANCE TO BIOLOGICAL THERAPY IN INFLAMMATORY BOWEL DISEASE MOLECULAR RESISTANCE TO BIOLOGICAL THERAPY IN INFLAMMATORY BOWEL DISEASE
IMMUNOLOGICAL MECHANISMS BEHIND RESISTANCE TO BIOLOGICAL THERAPY IN INFLAMMATORY BOWEL DISEASE MOLECULAR RESISTANCE TO BIOLOGICAL THERAPY IN INFLAMMATORY BOWEL DISEASE

IBD (Posters)

THE NATURAL HISTORY OF COVID-19 IN PATIENTS WITH IBD: A NATIONWIDE STUDY BY THE HELLENIC SOCIETY FOR THE STUDY OF IBD
THE NATURAL HISTORY OF COVID-19 IN PATIENTS WITH IBD: A NATIONWIDE STUDY BY THE HELLENIC SOCIETY FOR THE STUDY OF IBD

SERUM PREVALENCE OF SARS-COV2 ANTIBODIES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE BEFORE VACCINATION
SERUM PREVALENCE OF SARS-COV2 ANTIBODIES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE BEFORE VACCINATION

INTESTINAL FIBROBLASTS FROM CROHN'S DISEASE PATIENTS EXPRESSED INCREASED AUTOPHAGY AND DECREASED APOPTOSIS
INTESTINAL FIBROBLASTS FROM CROHN'S DISEASE PATIENTS EXPRESSED INCREASED AUTOPHAGY AND DECREASED APOPTOSIS

MY IBD CARE, A DIGITAL THERAPEUTIC FOR IBD, IS SAFE AND EFFECTIVE: CASE-CONTROL STUDY IN TWO UK CENTRES
MY IBD CARE, A DIGITAL THERAPEUTIC FOR IBD, IS SAFE AND EFFECTIVE: CASE-CONTROL STUDY IN TWO UK CENTRES

SIMPLIFIED RULES TO IDENTIFY BIO-NAÏVE PATIENTS WITH CROHN'S DISEASE WITH HIGHER LIKELIHOOD OF CLINICAL REMISSION WHEN INITIATING VEDOLIZUMAB VERSUS ANTI-TNF THERAPIES: ANALYSIS OF EVOLVE STUDY DATA
SIMPLIFIED RULES TO IDENTIFY BIO-NAÏVE PATIENTS WITH CROHN'S DISEASE WITH HIGHER LIKELIHOOD OF CLINICAL REMISSION WHEN INITIATING VEDOLIZUMAB VERSUS ANTI-TNF THERAPIES: ANALYSIS OF EVOLVE STUDY DATA

THE APA I POLYMORPHISM IN THE VITAMIN D RECEPTOR GENE IS ASSOCIATED WITH A STRICTURING BEHAVIOUR IN CROHN'S DISEASE PATIENTS
THE APA I POLYMORPHISM IN THE VITAMIN D RECEPTOR GENE IS ASSOCIATED WITH A STRICTURING BEHAVIOUR IN CROHN'S DISEASE PATIENTS

THE IBD DISK IS WELL CORRELATED WITH MUCOSAL DISEASE ACTIVITY AND MAYO SCORE IN PATIENTS WITH ULCERATIVE COLITIS
THE IBD DISK IS WELL CORRELATED WITH MUCOSAL DISEASE ACTIVITY AND MAYO SCORE IN PATIENTS WITH ULCERATIVE COLITIS

A MATCHING-ADJUSTED INDIRECT COMPARISON OF MAINTENANCE ORAL FILGOTINIB VERSUS INTRAVENOUS VEDOLIZUMAB FOR MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
A MATCHING-ADJUSTED INDIRECT COMPARISON OF MAINTENANCE ORAL FILGOTINIB VERSUS INTRAVENOUS VEDOLIZUMAB FOR MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS

STRUCTURAL ALTERATIONS OF COLONIC MICROVILLI IN MICROSCOPIC COLITIS AND RESTORATION BY ORAL BUDESONIDE
STRUCTURAL ALTERATIONS OF COLONIC MICROVILLI IN MICROSCOPIC COLITIS AND RESTORATION BY ORAL BUDESONIDE

FACTORS INDEPENDENTLY ASSOCIATED WITH FATIGUE IN IBD: RESULTS FROM THE BASELINE DATASET OF THE PREDICCT STUDY
FACTORS INDEPENDENTLY ASSOCIATED WITH FATIGUE IN IBD: RESULTS FROM THE BASELINE DATASET OF THE PREDICCT STUDY

PERFUSE: A FRENCH NON-INTERVENTIONAL COHORT STUDY OF ADALIMUMAB-NAÏVE AND TRANSITIONED PATIENTS RECEIVING ADALIMUMAB BIOSIMILAR SB5; BASELINE RESULTS
PERFUSE: A FRENCH NON-INTERVENTIONAL COHORT STUDY OF ADALIMUMAB-NAÏVE AND TRANSITIONED PATIENTS RECEIVING ADALIMUMAB BIOSIMILAR SB5; BASELINE RESULTS

Item 41 - 60 / 568
1 2
3
4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29